Stock Market News
Latest financial news · Updated May 24, 2026
Soybeans Extending Back Lower to Start the Midweek Session
The panel is divided on the soybean market's direction, with concerns about demand destruction and logistics issues in Brazil offsetting …
Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …
JD.com (JD) and BYD Enters a Strategic Partnership
The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …
Morgan Stanley Maintains a Buy on Block (XYZ)
The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …
The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now
The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …
Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …
Stellantis (STLA) Considering Partnerships With Chinese Automakers
The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …
U.S. Stocks Climb Well Off Worst Levels But Still Close Lower
The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?
The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …
G2 Investment Partners Initiates a New Position in Xometry
Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …
SBSW Makes Notable Cross Below Critical Moving Average
The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …